TickerFactsScreenerDevelopers

Actinium Pharmaceuticals, Inc. (ATNM) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2010: $7.8K2011: -$517.6K2012: -$5.21M2013: -$6.29M2014: -$14.35M2015: -$18.54M2016: -$20.79M2017: -$21.55M2018: -$20.57M2019: -$21.46M2020: -$21.62M2021: -$20.87M2022: $8.64M2023: -$47.34M2024: -$33.07M2025: -$24.58M-$24.58M
2010Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$24.58M+25.7%
2024-$33.07M+30.1%
2023-$47.34M-647.6%
2022$8.64M+141.4%
2021-$20.87M+3.5%
2020-$21.62M-0.7%
2019-$21.46M-4.3%
2018-$20.57M+4.6%
2017-$21.55M-3.7%
2016-$20.79M-12.1%
2015-$18.54M-29.2%
2014-$14.35M-128.0%
2013-$6.29M-20.7%
2012-$5.21M-907.1%
2011-$517.6K-6706.2%
2010$7.8K—